"The University of Illinois College of Medicine Peoria is one of four campuses that make up the nation’s largest public medical school. The Peoria campus is known among students for its small class sizes, rigorous curriculum and hands-on clerkships; to residents and fellows for the strong academic setting, large referral base and exceptional facilities; and by physicians seeking the ideal combination of teaching and practicing medicine in a research-based university setting."

During the past decade, University of Illinois College of Medicine at Peoria conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Illinois College of Medicine at Peoria" #1 sponsor was "Baxalta now part of Shire" with 1 trials, followed by "Cyberonics, Inc." with 1 trials sponsored, "Gynecologic Oncology Group" with 1 trials sponsored, "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored and "Johns Hopkins University" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Illinois College of Medicine at Peoria" #1 collaborator was "Children's Oncology Group (COG)" with 1 trials as a collaborator, "GN Otometrics" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "National Institute on Deafness and Other Communication Disorders (NIDCD)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "University of Illinois College of Medicine at Peoria" are "Cervical Cancer" (1 trials), "Childhood Obesity" (1 trials), "Chronic Fatigue Syndrome" (1 trials), "Constipation" (1 trials) and "Critical Confirmed Coronavirus Disease (COVID)-19" (1 trials). Many other conditions were trialed in "University of Illinois College of Medicine at Peoria" in a lesser frequency.

Most popular intervention types in "University of Illinois College of Medicine at Peoria" are "Drug" (6 trials), "Behavioral" (1 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Acetazolamide" (1 trials), "Cyclophosphamide" (1 trials), "Formal weight loss counselling program" (1 trials) and "Irinotecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Illinois College of Medicine at Peoria" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Illinois College of Medicine at Peoria". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of Illinois College of Medicine at Peoria, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Illinois College of Medicine at Peoria, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".